Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NKTR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
JRK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNAL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RUFY1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FNIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HERC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XRRA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP2M1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TFDP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSTF2T - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TOE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR82 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRRM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM104B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL11RA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on